Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease
Percutaneous coronary intervention of small-vessel coronary artery disease (SVD) remains challenging due to difficulties with device delivery and high restenosis rate, even with the use of newer-generation drug-eluting stents. Drug-coated balloons represent an attractive emerging percutaneous corona...
Main Authors: | Michael Megaly, Marwan Saad, Emmanouil S Brilakis |
---|---|
Format: | Article |
Language: | English |
Published: |
Radcliffe Medical Media
2019-01-01
|
Series: | US Cardiology Review |
Online Access: | https://www.uscjournal.com/articleindex/usc.2019.4.1 |
Similar Items
-
Drug-coated Balloons for Small Coronary Vessel Interventions: A Literature Review
by: Thomas Nestelberger, et al.
Published: (2019-11-01) -
Drug-Coated Balloon versus Drug-Eluting Stent in Patients with Small-Vessel Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials
by: Xinying Wu, et al.
Published: (2021-01-01) -
Spontaneous coronary artery dissection: Primum non nocere
by: Iosif Xenogiannis, et al.
Published: (2020-05-01) -
Drug Coated Balloon-Only Strategy in De Novo Lesions of Large Coronary Vessels
by: Mark Rosenberg, et al.
Published: (2019-01-01) -
Efficacy of Low-Pressure Inflation of Oversized Drug-Coated Balloon for Coronary Artery Disease
by: Katsumi Ueno, et al.
Published: (2020-01-01)